CJC-1295 research guide

CJC-1295 in Ohaba — GHRH Analog Research Guide

CJC-1295 research guide for Ohaba. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

CJC-1295 in Ohaba — Research & Sourcing Guide

For anyone in Ohaba trying to locate CJC-1295, the first thing to know is that this compound is available only through an online research supply market. The benefit of this online-only market is that serious vendors are judged entirely by their analytical documentation, giving researchers more rigorous quality data than local retail ever could. A properly operating CJC-1295 supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all corresponding to the vial you receive. The sections below cover what Ohaba researchers need to know about sourcing, verifying, and handling CJC-1295 for research purposes.

Understanding CJC-1295 — Biology & Evidence

CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Ohaba studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.

How to Source CJC-1295 — Vendor Guide

Quality CJC-1295 sourcing begins with a straightforward question: does this vendor share complete COA data without being asked? Those who make this data freely available are operating transparently. The HPLC analytical chromatogram is the most important document in the COA: it should show a clear dominant peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be 98% or higher. Positive vendor signals beyond COA quality: established track record of at least two years, knowledgeable support capable of explaining COA data, and cold chain packaging that protects product integrity. Store lyophilised CJC-1295 at freezer temperature (−20°C) until ready to use; reconstitute only the amount needed for the near-term protocol and keep the remainder frozen.

Order CJC-1295 — ships to Ohaba
COA-verified · International tracking · Research grade
Order Now →

CJC-1295: Storage, Reconstitution & Safety

As a research compound, CJC-1295 has not been through the clinical trial process required for pharmaceutical approval — its safety profile is characterised by preclinical data and small-scale human observations. Temperature excursions — even brief warming above recommended storage temperature — can cause partial degradation without visible changes; always verify cold chain was maintained during shipping. Endotoxin testing in the CJC-1295 COA is non-negotiable — gram-negative bacterial endotoxins can trigger severe inflammatory responses at minute levels, and no pricing advantage justifies skipping this verification. For any individual considering CJC-1295 outside a formal research context: seek medical advice first — this compound is unapproved for human therapeutic application and its risk profile is not equivalent to approved medications.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →